Mito, Japan

Masumi Umezawa

This inventor holds 26 USPTO granted patents and 2 published patent applications and 10 EPO patents, primarily in Particle Therapy Systems. Top assignees: Hitachi, Ltd., Hokkaido University, Hitachi High-Tech Corporation. Active years: 1999-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masumi Umezawa. Retrieved from https://idiyas.com/inventor/masumi-umezawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 96.2

 

Average Co-Inventor Count = 4.0

ph-index = 14

Forward Citations = 1,534(Granted Patents)


Location History:

  • Hitachi, JP (1999 - 2006)
  • Mito, JP (2008 - 2016)
  • Tokyo, JP (2015 - 2024)

Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Particle Beam Therapy
Charged Particle Beam
Dose Distribution Evaluation
Irradiation System
Medical Treatment System
Accelerator Technology
Treatment Planning
Magnetic Resonance Imaging
Electromagnet
Scanning Path Calculation
Particle Therapy
26 patents (USPTO):Explore Patents

Title: **Masumi Umezawa: Pioneering Innovations in Particle Therapy Systems**

Introduction

Masumi Umezawa, an accomplished inventor based in Mito, Japan, has made significant contributions to the field of particle therapy systems, holding a remarkable total of 25 patents. His innovative approaches have advanced medical technology, particularly in cancer treatment applications.

Latest Patents

Among Umezawa's latest inventions are three notable patents that enhance the functionality of proton beam therapy systems. The first, a **particle therapy system**, includes an irradiation nozzle for directing a particle beam towards a target. It features a proton beam irradiation control system that manages this nozzle, as well as a dose monitor that accurately measures the irradiation amount delivered to the target. Additionally, a position monitor tracks the beam's trajectory, while a dose distribution evaluation system calculates the particle beam's dosage during treatment. This system plays a crucial role in assisting medical staff in making timely and appropriate treatment decisions.

Another key invention is an **accelerator and particle beam irradiation system**. This technology employs an accelerator designed with a circular vacuum container, which incorporates a pair of circular return yokes. The layout features six magnetic poles that are arranged radially from the injection electrode, enabling efficient extraction of ion beams. This system not only enhances the precision of beam trajectories but also optimizes treatment efficacy for patients undergoing particle therapy.

Career Highlights

Throughout his career, Umezawa has been affiliated with prestigious organizations like Hitachi, Ltd. and the National University Corporation Hokkaido University. His experience in these institutions has allowed him to lead groundbreaking research and development projects in the field of particle therapy.

Collaborations

Umezawa has had the privilege of collaborating with notable colleagues in his field, including Kazuo Hiramoto and Hideaki Nishiuchi. These partnerships have fostered an environment of innovation and have resulted in advancements that benefit medical technology and patient care.

Conclusion

Masumi Umezawa stands out as a key figure in the field of particle therapy technology. With his impressive portfolio of patents and his commitment to advancing medical treatment, Umezawa continues to be an influential innovator in the healthcare industry. His work not only exemplifies the spirit of invention but also highlights the importance of collaboration in achieving groundbreaking advancements in medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…